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In the above-mentioned paper, the expression of PPARγ
was incorrectly determined based on the quantiﬁcation of
a 50kD band on the Western blots. This band aligned with
what was believed to be a positive control band in the
U937 whole cell extract, a control reagent recommended
by the supplier of the primary antibody, SC-7196 (Santa
Cruz Biotechnologies, Santa Cruz, CA). Based on recent
information described by Foreman et al. [1], it is clear that
this band is not PPARγ but was a nonspeciﬁc immunoreac-
tive protein detected by SC-7196. This nonspeciﬁc protein
was abundantly detected by SC-7196 in U937 and COS-
1 cells as well as across all human fetal protein samples.
Immunoprecipitation of COS-1 cell lysate using agarose-
conjugatedSC-7196resultedinasingle bandonaCoomassie
Blue-stained gel. This band was subjected to digestion,
peptide extraction, and sequence analysis using MALDI-
MSMS, and the protein was identiﬁed as cytoplasmic actin
with a decisive score (human SwissProt database, 60%
protein coverage using the 15 highest scoring peptide groups
and two lower scoring but acceptable peptides).
As p e c i ﬁ cb a n df o rP P A R γ, (calculated molecular weight
for human PPARγ1 = 54.55kD) was identiﬁed on our
Western blots by performing new experiments in which in
vitrotranslated humanPPARγ1 (providedby J. Peters, Penn-
sylvania State University) was compared with human fetal
tissue lysates (Figure 1). These experiments also included
COS-1 cell lysate as a negative control and U937 cell lysate.
TheWesternblotsofthefetaltissueswereallreanalyzedusing
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Figure 1: Western blot showing the comparison of banding
patterns in COS-1 cell lysate, U937 cell lysate, in vitro translated
human PPARγ1, and tissue lysate from human fetal stomach
samples. The ∼55 kD band of human PPARγ1 and corresponding
band in stomach tissue lysate is marked with an asterisk (∗). The
nonspeciﬁc, cytoplasmic actin band is marked with an arrow.
the ∼55kD band that aligned with the in vitro translated
human PPARγ1. Based on this reanalysis, the expression of
PPARγ protein shown in (c) of Figures 1–9 are replaced
by Figure 2. The data summary described in Table 1 of
the above-mentioned paper regarding the change in PPARγ
protein expression with fetal age is replaced by Table 1.2 PPAR Research
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Figure 2: PPARγ protein expression is shown across the fetal age range for each tissue. Western blot density normalized to glyceraldehyde-
3-phophate dehydrogenase (GAPDH). If only one sample was available for a particular age, then an error term could not be calculated and
no SEM bar is shown. Regression analysis evaluated change with age. Dashed lines are the 95% conﬁdence interval.
Table 1
Tissue Protein change with age
Thymus NS
Intestine Increase P<. 01
Spleen Decrease P<. 001
Liver Increase P<. 05
Kidney Decrease P<. 05
Lung Decrease P<. 001
Stomach NS
Heart Decrease P<. 05
Adrenal Decrease P<. 05
NS = no signiﬁcant change with age.
The authors regret this unexpected error. The clariﬁca-
tion of the recognition patterns of this primary antibody
should be of value to investigators interested in detecting
PPARγ protein.
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